Originality has always been a part of patent law. It bars patents that are obtained by copying from someone or from somewhere. Modern judicial interpretations of the patent act have ignored this second element of originality. But as originality is, at least arguably, a constitutional limit of the Patent and Copyright clause, the courts must interpret the patent act consistently to include originality. As a specific example, the paper focuses on patents claiming isolated and purified naturally-occurring gene sequences. The paper concludes that such patents are not original – they are instead just the result of copying – and thus they are invalid
The US Supreme Court’s recent decision in Association for Molecular Pathology v. Myriad Genetics, In...
On April 15, 2013, the U.S. Supreme Court heard oral arguments in Association for Molecular Patholog...
This Article examines the recent history of the ways in which the courts have applied the written de...
Originality has always been a part of patent law. It bars patents that are obtained by copying from ...
In supporting gene patents, the patent office, the courts and other supporters have assumed that gen...
This editorial examines the logical structure of the United States Supreme Court decision in Myriad ...
This comment proposes a totality-of-the-circumstances approach to analyzing biological molecules und...
The emergence of genetic medicine following decades of molecular biology research has been accompa...
By the summer of 2013, the United States Supreme Court should issue an opinion in Myriad v. AMP, a c...
A patent holder can choose to license a patented invention to others, can choose to use the patented...
Gene patents have proven to be enormously controversial, evoking a strong response from many categor...
This Article submits that the main problem with gene patents is the failure to meet the condition of...
A revolution in genetics has been occurring since Watson and Crick discovered the structure of the d...
This is the peer reviewed version of the following article: [A hidden technological assumption in pa...
When Congress enacted the United States Patent Act in 1952, it specified that patentable subject mat...
The US Supreme Court’s recent decision in Association for Molecular Pathology v. Myriad Genetics, In...
On April 15, 2013, the U.S. Supreme Court heard oral arguments in Association for Molecular Patholog...
This Article examines the recent history of the ways in which the courts have applied the written de...
Originality has always been a part of patent law. It bars patents that are obtained by copying from ...
In supporting gene patents, the patent office, the courts and other supporters have assumed that gen...
This editorial examines the logical structure of the United States Supreme Court decision in Myriad ...
This comment proposes a totality-of-the-circumstances approach to analyzing biological molecules und...
The emergence of genetic medicine following decades of molecular biology research has been accompa...
By the summer of 2013, the United States Supreme Court should issue an opinion in Myriad v. AMP, a c...
A patent holder can choose to license a patented invention to others, can choose to use the patented...
Gene patents have proven to be enormously controversial, evoking a strong response from many categor...
This Article submits that the main problem with gene patents is the failure to meet the condition of...
A revolution in genetics has been occurring since Watson and Crick discovered the structure of the d...
This is the peer reviewed version of the following article: [A hidden technological assumption in pa...
When Congress enacted the United States Patent Act in 1952, it specified that patentable subject mat...
The US Supreme Court’s recent decision in Association for Molecular Pathology v. Myriad Genetics, In...
On April 15, 2013, the U.S. Supreme Court heard oral arguments in Association for Molecular Patholog...
This Article examines the recent history of the ways in which the courts have applied the written de...